查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190957

冠狀動脈血流儲備分數 (FFR) 市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Fractional Flow Reserve Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

由於心血管疾病患病率上升和新興產品趨勢，預計冠狀動脈血流儲備分數 (FFR) 市場在預測期內的複合年增長率為 13.2%。

主要亮點

  • 心髒病是全世界死亡的主要原因。 根據世界衛生組織的數據，2017 年約有 1790 萬人死於與心臟相關的疾病。 此外，世界上近四分之三的心血管疾病死亡發生在低收入和中等收入國家。
  • 此外，ACIST Medical Systems 在 2017 年發布了 FFR 系統“RXi Mini System”。 它旨在測量與血管造影互補的血壓流量。 因此，這產生了對部分流量儲備導絲和系統的需求。

冠狀動脈血流儲備分數 (FFR) 的市場趨勢

冠脈血流儲備（FFR）市場，導絲板塊有望佔據較大份額

  • 壓力導絲在手術中用於確定是否有任何心臟血管或動脈需要手術。 它還可以作為到達病灶的導航工具。 血管造影術的增加及其獨特的特性預計將對市場產生積極影響。
  • 根據《Deutsches Arzteblatt International》雜誌發表的一項研究，2019 年，德國每年進行約 80,000 例冠狀動脈造影手術。 此外，在冠狀動脈造影過程中引入壓力導絲成功地了解了冠狀動脈狹窄的血流動力學。

北美市場佔有很大份額，預計在預測期內保持不變

由於人口老齡化和相關的心血管疾病增加，預計北美將佔據冠狀動脈血流儲備分數 (FFR) 市場的很大份額。 根據美國疾病控制和預防中心的數據，2016 年約有 2620 萬人被診斷出患有心髒病，使冠狀動脈疾病成為美國被診斷出最多的心髒病。 根據美國心臟協會的數據，每年約有 720,000 人患心髒病。 因此，這些因素有望推動分流儲備市場的增長。

冠狀動脈血流儲備分數 (FFR) 市場的競爭分析

市場是分散的，由幾個主要參與者組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 每家公司為產品開發採取的戰略舉措預計將促進市場的增長。 例如，2019 年 Koninklijke Philips NV 推出了 IntraSight 介入應用平台，提供 iFR、FFR 和 IVUS 解決方案。 目前主導市場的公司包括 Opsens Medical、Abbott、Boston Scientific、GE Healthcare、Siemens Healthcare、Cathworks、Medis Medical Imaging System、Pie Medical Imaging BV、Heartflow Inc 和 Koninklijke Philips NV。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查先決條件
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加心血管疾病的負擔
    • 產品進度
  • 市場製約因素
    • 嚴格的監管框架
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品類型
    • FFR 系統
    • 導絲
  • 按技術
    • 侵入性
    • 非侵入性
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbott
    • Boston Scientific
    • Cathworks
    • GE Healthcare
    • Heartflow Inc.
    • Koninklijke Philips NV
    • Medis Medical Imaging System
    • Opsens Medical
    • Pie Medical Imaging BV
    • Siemens Healthcare

第7章 市場機會今後動向

簡介目錄
Product Code: 68382

The fractional flow reserve market is expected to register a CAGR of 13.2% during the forecast period due to higher prevalence of cardiovascular diseases and emerging trends in product.

Key Highlights

  • Heart disease is the leading cause of death worldwide. According to the World Health Organization, in 2017, around 17.9 million people died due to heart related diseases. Moreover, almost ¾ of death globally occurring due to cardiovascular diseases is observed in low- and middle-income countries.
  • Furthermore, in 2017, ACIST Medical Systems introduced an FFR system, RXi Mini System. It is designed to measure blood pressure flow in complement with angiography. Hence, this arises the demand for fractional flow reserve guide-wires and system.

Fractional Flow Reserve Market Trends

Guidewires Segment is Expected to Hold a Major Market Share in the Fractional Flow Reserve Market

  • Pressure guide-wires are used in procedures to determine if any surgery is required in vessels or arteries of the heart. It also acts as a navigator tool to reach the lesion. The growing number of angiography and its unique characteristics are expected to influence positively on the market.
  • According to the study published by journal Deutsches Arzteblatt International, in 2019, around 80,000 procedures of coronary angiography are performed every year in Germany. Furthermore, when pressure guide-wire was introduced during coronary angiography, the hemodynamic of coronary stenosis was successfully determined.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the fractional flow reserve market due to the increasing geriatric population and associated cardiovascular diseases. According to the Center for Disease Control and Prevention, in 2016, approximately 26.2 million people were diagnosed with heart disease and coronary artery disease is the most diagnosed heart disease in United States. Also, according to the American Heart Association, the incidence rate of heart attack is around 720,000 annually. Hence, these factors are expected to propel the fractional flow reserve market growth.

Fractional Flow Reserve Market Competitive Analysis

The market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Strategic initiatives taken by companies to develop the product is expected to boost market growth. For instance, in 2019, Koninklijke Philips NV launched an IntraSight Interventional applications platform that offers iFR, FFR, and IVUS solution. Some of the companies that are currently dominating the market are Opsens Medical, Abbott, Boston Scientific, GE Healthcare, Siemens Healthcare, Cathworks, Medis Medical Imaging System, Pie Medical Imaging BV, Heartflow Inc., and Koninklijke Philips NV.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Advancments in Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 FFR System
    • 5.1.2 Guidewire
  • 5.2 By Technology
    • 5.2.1 Invasive
    • 5.2.2 Non-invasive
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Boston Scientific
    • 6.1.3 Cathworks
    • 6.1.4 GE Healthcare
    • 6.1.5 Heartflow Inc.
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Medis Medical Imaging System
    • 6.1.8 Opsens Medical
    • 6.1.9 Pie Medical Imaging BV
    • 6.1.10 Siemens Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS